News & Events

News & Events2022-09-20T15:38:17+02:00

Read FIN’s latest updates, upcoming events and all news relating to Fabry Disease here

News from Chiesi

June 29th, 2023|Industry News, News|

Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce European Commission Authorization of PRX-102 (pegunigalsidase alfa) for the Treatment of Fabry Disease

News from Freeline

December 13th, 2021|Industry News, News|

Freeline announced new data from its ongoing Phase 1/2 MARVEL-1 dose-finding clinical trial of FLT190 for the treatment of Fabry disease and provided updates on its pipeline programs. 

News from Idorsia

December 13th, 2021|Industry News, News|

Idorsia Ltd (SIX: IDIA) today announced that after the planned interim analysis of the open-label extension (OLE) of the Phase 3 MODIFY study with lucerastat for the treatment of adult patients with Fabry disease, the study will continue.

October 20th, 2021|News|

Rare disease community calls for additional doses of COVID-19 vaccine to protect the most vulnerable and extra measures to vaccinate more European citizens

Nordic Rare Disease Summit

June 18th, 2021|News|

The Nordic Rare Disease Summit, organized as a virtual meeting on 12th and 13th of April 2021, gathered a wide range of rare disease experts, decision- and policymakers as well as representatives from NGO’s, patient organizations, academia and industry from across the Nordic countries

Open letter to Fabry Centres

May 6th, 2021|News|

To highlight the need for continuous care and monitoring for Fabry disease patients and remind everyone of action needed for newly diagnosed patients, those in the midst of the diagnostic process or those experiencing symptoms for the first time and needing assessment We want to emphasise the need for ongoing clear and consistent communication from the centres about patients’ care and having regular appointments (in-person or telehealth)

Treatment needs and expectations for Fabry disease in France

February 19th, 2021|News|

development of a new Patient Needs Questionnaire In France, two associations actively represent Fabry patients, participate in and promote medical research: Association des Patients de la Maladie de Fabry (APMF, and Vaincre les Maladies Lysosomales (VML,

Recent Newsletters

Go to Top